108 - Pharmacy Forecasting – Not Just for Pharmacy Actuaries Anymore

Member Price $300.00
Non-Member Price $200.00

The pharmaceutical landscape has been changing rapidly in the last decade. More and more of the spend on pharmaceutical drugs is being shifted to the medical benefit. Oncology, gene therapy, and many of the immunomodulators are now administered in a doctor’s office. New methods of forecasting and benefit management need to be considered when looking to the future. Where will these techniques come from? In this session the presenters discuss the history of pharmacy benefit forecasting and management and the emerging techniques that require a unique combination of methodologies from other actuarial disciplines.


Michael S. Clark

River and Mercantile

Derek N. Guyton

Edward M. Pudlowski

MorningStar Actuarial Consulting, LLC

James L. Jones - EY

Tasha Eurich


CPD Credit EA Core Credit EA Ethics Credit EA Non-Core Credit EA Formal Credit